You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 2, 2025

Details for Patent: 11,090,261


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 11,090,261 protect, and when does it expire?

Patent 11,090,261 protects RYZUMVI and is included in one NDA.

This patent has ten patent family members in eight countries.

Summary for Patent: 11,090,261
Title:Aqueous ophthalmic solutions of phentolamine and medical uses thereof
Abstract:The invention provides aqueous ophthalmic solutions of phentolamine or pharmaceutically acceptable salts thereof, medical kits, and methods for using such ophthalmic solutions to improve visual performance in a patient. Exemplary aqueous ophthalmic solutions include those containing phentolamine mesylate, mannitol, sodium acetate, and water.
Inventor(s):Alan Meyer
Assignee:Ocuphire Pharma Inc
Application Number:US16/398,536
Patent Claim Types:
see list of patent claims
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 11,090,261: A Comprehensive Analysis

Introduction

When analyzing a patent, particularly one like United States Patent 11,090,261, it is crucial to delve into the scope and claims to understand its implications and the landscape it operates within. This article will provide a detailed analysis of these aspects, leveraging insights from recent patent guidance updates, patent analytics, and legal precedents.

Understanding Patent Claims

Patent claims are the most critical part of any patent application, as they define the scope of the invention and what is protected by the patent[3].

Claim Structure and Importance

Claims in a patent are structured to clearly outline what the inventor considers to be the novel and non-obvious aspects of the invention. Each claim must be carefully crafted to ensure it meets the criteria for patent eligibility, particularly in the context of recent updates and legal interpretations.

The 2024 USPTO Guidance Update on AI Patent Eligibility

The 2024 USPTO guidance update, prompted by Executive Order 14110, provides significant clarifications on the patent eligibility of AI-related inventions. This update is particularly relevant when analyzing patents that involve AI or similar technologies.

Integrating Judicial Exceptions into Practical Applications

The guidance emphasizes the importance of integrating judicial exceptions (such as abstract ideas or natural phenomena) into practical applications. For a claim to be patent-eligible, it must show that the abstract idea is applied in a way that provides concrete benefits or solves specific problems in the relevant field[1].

AI-Assisted Inventions

The update also clarifies that the method of invention development, including the use of AI, does not impact subject matter eligibility. Instead, the focus remains on the claimed invention itself, ensuring that AI-assisted inventions are evaluated on equal footing with other technologies[1].

Analyzing the Scope of United States Patent 11,090,261

To analyze the scope of this patent, one must examine the claims and how they align with the recent USPTO guidance.

Claim-by-Claim Analysis

Each claim in the patent must be evaluated to determine if it integrates any judicial exceptions into a practical application. For example, if a claim involves data processing using AI, it must specify how this processing is applied in a real-world scenario to enhance technology or provide a practical benefit.

Practical Applications and Real-World Benefits

Claims that merely use mathematical models or data processing without applying the data in a specific manner that improves technology or provides a practical application are likely to be considered ineligible. In contrast, claims that specify the use of AI in a real-time system, such as speech recognition or medical diagnosis, and demonstrate tangible outcomes, are more likely to be patent-eligible[1].

Patent Landscape and Analytics

Understanding the broader patent landscape is crucial for assessing the value and coverage of a patent.

Patent Analytics and Claim Coverage

Patent analytics tools, such as those provided by Schwegman, help in categorizing patents by claims and scope concepts. This approach allows for the identification of gaps or opportunities in patent coverage and helps in determining the value of each claim to the company[3].

Claim Charts and Scope Concepts

Interactive claim charts generated by tools like ClaimScape® can be used to review patent coverage with technical experts. These charts help in identifying whether a particular scope concept is applicable to a target product or method, highlighting areas where claim coverage may be lacking and suggesting future design opportunities[3].

Legal Precedents and Case Law

Recent court decisions and legal precedents also play a significant role in shaping the interpretation of patent claims.

Case Law and Judicial Interpretations

Cases like In re Cellect highlight the complexities of patent validity and the importance of careful claim drafting. The Federal Circuit's decisions on obviousness-type double patenting and patent term adjustments underscore the need for meticulous analysis of patent claims and their interrelations[2].

Key Takeaways

  • Integrate Judicial Exceptions: Ensure that claims integrate abstract ideas into practical applications to meet patent eligibility criteria.
  • AI-Assisted Inventions: The use of AI in invention development does not affect subject matter eligibility; focus on the claimed invention itself.
  • Practical Applications: Claims must demonstrate real-world benefits and tangible outcomes to be considered patent-eligible.
  • Patent Analytics: Use analytics tools to categorize patents by claims and scope concepts to identify gaps and opportunities.
  • Legal Precedents: Stay updated with recent court decisions to ensure compliance with evolving legal interpretations.

FAQs

  1. What is the significance of the 2024 USPTO guidance update on AI patent eligibility?

    • The update provides clarifications on integrating judicial exceptions into practical applications, ensuring AI-assisted inventions are evaluated equally, and highlighting the importance of real-world benefits.
  2. How do patent analytics tools help in managing patent claims?

    • These tools categorize patents by claims and scope concepts, helping to identify gaps in coverage, determine the value of claims, and highlight future design opportunities.
  3. What is the importance of specifying practical applications in patent claims?

    • Specifying practical applications ensures that the claim integrates abstract ideas into tangible outcomes, making it more likely to be patent-eligible.
  4. How do recent court decisions impact the interpretation of patent claims?

    • Recent decisions, such as In re Cellect, emphasize the need for careful claim drafting and understanding of interrelated patents to avoid issues like obviousness-type double patenting.
  5. What role does AI play in the patent eligibility of inventions?

    • AI's role as a tool does not exclude inventions from eligibility, provided there is significant human contribution and the claimed invention itself meets the criteria for patent eligibility.

Sources

  1. Understanding the 2024 USPTO Guidance Update on AI Patent Eligibility - Mintz
  2. In re Cellect - United States Court of Appeals for the Federal Circuit
  3. Patent Analytics | Intellectual Property Law - Schwegman
  4. What Is the Probability of Receiving a US Patent? - Yale Journal of Law and Technology
  5. U.S. Patent and Trademark Office (USPTO) - USAGov

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 11,090,261

Showing 1 to 1 of 1 entries

International Family Members for US Patent 11,090,261

CountryPatent NumberEstimated ExpirationSupplementary Protection CertificateSPC CountrySPC Expiration
Australia 2014212274 ⤷  Try for Free
Australia 2018200566 ⤷  Try for Free
Canada 2899339 ⤷  Try for Free
Denmark 2950648 ⤷  Try for Free
European Patent Office 2950648 ⤷  Try for Free
Spain 2762153 ⤷  Try for Free
>Country>Patent Number>Estimated Expiration>Supplementary Protection Certificate>SPC Country>SPC Expiration
Showing 1 to 6 of 6 entries

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.